Home / News / India News / Article /
Only 311 of 1.9 million Covaxin beneficiaries reported side effects: Government
Updated On: 12 March, 2021 08:20 AM IST | New Delhi | IANS
The licensure of Covaxin has been changed to emergency use authorisation from earlier approved restricted emergency use in clinical trial mode by India's drug regulatory authority
Listen to this article :
A senior citizen takes a COVID-19 vaccine shot. Pic/Ashish Raje
Bharat Biotech's Covaxin has a negligible number of side effects reported among the beneficiaries of the Covid-19 vaccine, NITI Aayog's Member (Health), V.K. Paul said on Thursday.
"The vaccine has been administered so far to 19 lakh people and only 311 individuals of them have reported minimal side effects.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT